Description of Casi Pharmaceuticals Inc's Business Segments

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

(Dec 31 2025) three months ended Q4
Business Segments	Revenues (in millions $)	Income (in millions $)	% (Profit Margin)
Total	20.71	-48.06	-

(Dec 31 2025) three months ended Q4
Revenue Growth rates by Segment	Y/Y Revenue %	Q/Q Revenue %
Total	-27.42 %	-

(Dec 31 2025) three months ended Q4
Income Growth rates by Segment	Y/Y Income %	Q/Q Income %
Total	-	-

Annual Report on Casi Pharmaceuticals inc Divisions, Sales by Country

Twelve months ended 2025
CASIF s Annual Revenue by Geography and Business Segments	Sales (in millions $)	% (of total Sales)
Total	20.71	100 %

Twelve months ended 2025
CASIF s Annual Income by Country and Business Segments	Income (in millions $)	% (Profit Margin)
Total	-48.06	-

Twelve months ended 2025
Annual Revenue and Income Growth by Country and Business Segments	% Y/Y Sales Growth	% Y/Y Income Growth

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.